Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck; results from a randomized clinical trial
β Scribed by J.J. Fischer; B.G Haffty; Y.H. Son; D. Fischer; C.T Sasaki; R Papac; S Rockwell; A.C. Sarore
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 118 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The purpose of this study was to determine the efficacy of mitomycin C as an adjunct to radiotherapy for the treatment of locally advanced cervix cancer. Patients with squamous-cell carcinoma of the cervix, stages IB2-IVA, were randomized to receive radiotherapy alone or radiotherapy with concomitan
## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the
The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.